Cargando…

European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults

BACKGROUND: To guide decision-making on immunisation programmes for ageing adults in Europe, one of the aims of the Vaccines and InfecTious diseases in the Ageing popuLation (IMI2-VITAL) project is to assess the burden of disease (BoD) of (potentially) vaccine-preventable diseases ((P)VPD). We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Méroc, Estelle, Fröberg, Janeri, Almasi, Timea, Winje, Brita Askeland, Orrico-Sánchez, Alejandro, Steens, Anneke, McDonald, Scott A., Bollaerts, Kaatje, Knol, Mirjam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042717/
https://www.ncbi.nlm.nih.gov/pubmed/33849461
http://dx.doi.org/10.1186/s12879-021-06017-7
_version_ 1783678175046270976
author Méroc, Estelle
Fröberg, Janeri
Almasi, Timea
Winje, Brita Askeland
Orrico-Sánchez, Alejandro
Steens, Anneke
McDonald, Scott A.
Bollaerts, Kaatje
Knol, Mirjam J.
author_facet Méroc, Estelle
Fröberg, Janeri
Almasi, Timea
Winje, Brita Askeland
Orrico-Sánchez, Alejandro
Steens, Anneke
McDonald, Scott A.
Bollaerts, Kaatje
Knol, Mirjam J.
author_sort Méroc, Estelle
collection PubMed
description BACKGROUND: To guide decision-making on immunisation programmes for ageing adults in Europe, one of the aims of the Vaccines and InfecTious diseases in the Ageing popuLation (IMI2-VITAL) project is to assess the burden of disease (BoD) of (potentially) vaccine-preventable diseases ((P)VPD). We aimed to identify the available data sources to calculate the BoD of (P)VPD in participating VITAL countries and to pinpoint data gaps. Based on epidemiological criteria and vaccine availability, we prioritized (P) VPD caused by Extra-intestinal pathogenic Escherichia coli (ExPEC), norovirus, respiratory syncytial virus, Staphylococcus aureus, and pneumococcal pneumonia. METHODS: We conducted a survey on available data (e.g. incidence, mortality, disability-adjusted life years (DALY), quality-adjusted life years (QALY), sequelae, antimicrobial resistance (AMR), etc.) among national experts from European countries, and carried out five pathogen-specific literature reviews by searching MEDLINE for peer-reviewed publications published between 2009 and 2019. RESULTS: Morbidity and mortality data were generally available for all five diseases, while summary BoD estimates were mostly lacking. Available data were not always stratified by age and risk group, which is especially important when calculating BoD for ageing adults. AMR data were available in several countries for S. aureus and ExPEC. CONCLUSION: This study provides an exhaustive overview of the available data sources and data gaps for the estimation of BoD of five (P) VPD in ageing adults in the EU/EAA, which is useful to guide pathogen-specific BoD studies and contribute to calculation of (P)VPDs BoD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06017-7.
format Online
Article
Text
id pubmed-8042717
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80427172021-04-14 European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults Méroc, Estelle Fröberg, Janeri Almasi, Timea Winje, Brita Askeland Orrico-Sánchez, Alejandro Steens, Anneke McDonald, Scott A. Bollaerts, Kaatje Knol, Mirjam J. BMC Infect Dis Research Article BACKGROUND: To guide decision-making on immunisation programmes for ageing adults in Europe, one of the aims of the Vaccines and InfecTious diseases in the Ageing popuLation (IMI2-VITAL) project is to assess the burden of disease (BoD) of (potentially) vaccine-preventable diseases ((P)VPD). We aimed to identify the available data sources to calculate the BoD of (P)VPD in participating VITAL countries and to pinpoint data gaps. Based on epidemiological criteria and vaccine availability, we prioritized (P) VPD caused by Extra-intestinal pathogenic Escherichia coli (ExPEC), norovirus, respiratory syncytial virus, Staphylococcus aureus, and pneumococcal pneumonia. METHODS: We conducted a survey on available data (e.g. incidence, mortality, disability-adjusted life years (DALY), quality-adjusted life years (QALY), sequelae, antimicrobial resistance (AMR), etc.) among national experts from European countries, and carried out five pathogen-specific literature reviews by searching MEDLINE for peer-reviewed publications published between 2009 and 2019. RESULTS: Morbidity and mortality data were generally available for all five diseases, while summary BoD estimates were mostly lacking. Available data were not always stratified by age and risk group, which is especially important when calculating BoD for ageing adults. AMR data were available in several countries for S. aureus and ExPEC. CONCLUSION: This study provides an exhaustive overview of the available data sources and data gaps for the estimation of BoD of five (P) VPD in ageing adults in the EU/EAA, which is useful to guide pathogen-specific BoD studies and contribute to calculation of (P)VPDs BoD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06017-7. BioMed Central 2021-04-13 /pmc/articles/PMC8042717/ /pubmed/33849461 http://dx.doi.org/10.1186/s12879-021-06017-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Méroc, Estelle
Fröberg, Janeri
Almasi, Timea
Winje, Brita Askeland
Orrico-Sánchez, Alejandro
Steens, Anneke
McDonald, Scott A.
Bollaerts, Kaatje
Knol, Mirjam J.
European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults
title European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults
title_full European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults
title_fullStr European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults
title_full_unstemmed European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults
title_short European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults
title_sort european data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042717/
https://www.ncbi.nlm.nih.gov/pubmed/33849461
http://dx.doi.org/10.1186/s12879-021-06017-7
work_keys_str_mv AT merocestelle europeandatasourcesforcomputingburdenofpotentialvaccinepreventablediseasesinageingadults
AT frobergjaneri europeandatasourcesforcomputingburdenofpotentialvaccinepreventablediseasesinageingadults
AT almasitimea europeandatasourcesforcomputingburdenofpotentialvaccinepreventablediseasesinageingadults
AT winjebritaaskeland europeandatasourcesforcomputingburdenofpotentialvaccinepreventablediseasesinageingadults
AT orricosanchezalejandro europeandatasourcesforcomputingburdenofpotentialvaccinepreventablediseasesinageingadults
AT steensanneke europeandatasourcesforcomputingburdenofpotentialvaccinepreventablediseasesinageingadults
AT mcdonaldscotta europeandatasourcesforcomputingburdenofpotentialvaccinepreventablediseasesinageingadults
AT bollaertskaatje europeandatasourcesforcomputingburdenofpotentialvaccinepreventablediseasesinageingadults
AT knolmirjamj europeandatasourcesforcomputingburdenofpotentialvaccinepreventablediseasesinageingadults